Pharma News

AstraZeneca and MSD’s (Merck) PARP inhibitor Lynparza has demonstrated long-term progression-free survival (PFS) benefit in BRCA-mutated advanced ovarian cancer.

MSD (Merck) and Eisai have revealed new data from two trials under the LEAP clinical programme evaluating the combination of MSD’s PD-1 inhibitor Keytruda and Eisai’s oral tyrosine kinase ...

AstraZeneca has acquired a preclinical oral PCSK9 inhibitor programme from Dogma Therapeutics for an undisclosed price.

NICE has published draft guidance recommending Bristol-Myers Squibb's Opdivo (nivolumab) as a second-line treatment option for patients with squamous or non-squamous non-small-cell lung ca...

Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal Alzheimer's disease (AD)-related γ-secretase in rodents and macaques with...

Yet another rapid COVID-19 test has proven its mettle in spotting infection with the new coronavirus, this time in a British study.

NEW YORK (Reuters) - New York state filed civil charges on Thursday accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and ...

OSAKA, JAPAN, September 16, 2020 – Takeda Pharmaceutical Company Limited (TSE.

Eastman Kodak's pharma ambitions took a hit when insider trading accusations put $765 million in U.

BERLIN (Reuters) - Germany awarded $745 million in funding to biotech firms BioNTech and CureVac on Tuesday to speed up work on COVID-19 vaccines and expand German production capacity.

MADRID (Reuters) - Some volunteers have quit Johnson & Johnson’s COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca’s trial, the Spanish program...

BRUSSELS (Reuters) - The European Union will build its own agency for biomedical research and convene a global health summit in Italy next year in a bid to be better prepared for future pandem...